RESUMO
Bifidobacteria are a minor fraction of the human colon microbiota with interesting properties for carbohydrate degradation. Monosaccharides such as glucose and fructose are degraded through the bifid shunt, a dedicated pathway involving phosphoketolase activity. Its stoechiometry learns that three moles of acetate and two moles of lactate are produced per two moles of glucose or fructose that are degraded. However, deviations from this 3 : 2 ratio occur, depending on the rate of substrate consumption. Slower growth rates favour the production of acetate and pyruvate catabolites (such as formate) at the cost of lactate. Interestingly, bifidobacteria are capable to degrade inulin-type fructans (ITF) (oligofructose and inulin) and arabinoxylan-oligosaccharides (AXOS). Beta-fructofuranosidase activity enables bifidobacteria to degrade ITF. However, this property is strain-dependent. Some strains consume both fructose and oligofructose, with different preferences and degradation rates. Small oligosaccharides (degree of polymerization or DP of 2-7) are taken up, in a sequential order, indicating intracellular degradation and as such giving these bacteria a competitive advantage towards other inulin-type fructan degraders such as lactobacilli, bacteroides and roseburias. Other strains consume long fractions of oligofructose and inulin. Exceptionally, oligosaccharides with a DP of up to 20 (long-chain inulin) are consumed by specific strains. Also, the degradation of AXOS by α-arabinofuranosidase and ß-xylosidase is strain-dependent. Particular strains consume the arabinose substituents, whether or not together with a consumption of the xylose backbones of AXOS, either up to xylotetraose or higher and either extra- or intracellularly. The production of high amounts of acetate that accompanies inulin-type fructan degradation by bifidobacteria cross-feeds other colon bacteria involved in the production of butyrate. However, bifidobacterial strain-dependent differences in prebiotic degradation indicate the existence of niche-specific adaptations and hence mechanisms to avoid competition among each other and to favour coexistence with other colon bacteria.
Assuntos
Bifidobacterium/metabolismo , Metabolismo dos Carboidratos , Bifidobacterium/enzimologia , Bifidobacterium/crescimento & desenvolvimento , Inulina/metabolismo , Oligossacarídeos/metabolismo , Xilanos/metabolismo , Xilosidases , beta-Frutofuranosidase/metabolismoRESUMO
Cuprizone is a copper-chelating mitochondrial toxin that causes oligodendrocyte apoptosis and demyelination preferentially in the corpus callosum (CC) and the superior cerebellar peduncles, but not in the spinal cord (SC) of C57BL/6 mice. Here we aimed to determine the activities of copper-containing enzymes in correlation with the distribution of demyelination during exposure to cuprizone. The study revealed mitochondrial complex IV and superoxide dismutase activity alterations in both the pathology-affected CC and the non-affected SC. This observation raises the possibility that regionally different subcellular molecular interactions lead to the selective oligodendrocyte loss induced by the nonselective mitochondrial toxin, cuprizone.
Assuntos
Quelantes/toxicidade , Cuprizona/toxicidade , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/patologia , Mitocôndrias/efeitos dos fármacos , Oligodendroglia/efeitos dos fármacos , Animais , Morte Celular/efeitos dos fármacos , Corpo Caloso/efeitos dos fármacos , Corpo Caloso/enzimologia , Doenças Desmielinizantes/enzimologia , Modelos Animais de Doenças , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Mitocôndrias/enzimologia , Mitocôndrias/patologia , Oligodendroglia/enzimologia , Medula Espinal/efeitos dos fármacos , Medula Espinal/enzimologia , Medula Espinal/patologia , Superóxido Dismutase/efeitos dos fármacosRESUMO
Previous reports demonstrate that metformin, an anti-diabetic drug, can decrease the risk of cancer and inhibit cancer cell growth. However, its mechanism in cancer cells is still unknown. Metformin significantly blocks cell cycle and inhibits cell proliferation and colony formation of leukemic cells. However, the apoptotic response to metformin varies. Furthermore, daily treatment with metformin induces apoptosis and reduces tumor growth in vivo. While metformin induces early and transient activation of AMPK, inhibition of AMPKα1/2 does not abrogate anti-proliferative or pro-apoptotic effects of metformin. Metformin decreases electron transport chain complex I activity, oxygen consumption and mitochondrial ATP synthesis, while stimulating glycolysis for ATP and lactate production, pentose phosphate pathway for purine biosynthesis, fatty acid metabolism, as well as anaplerotic and mitochondrial gene expression. Importantly, leukemic cells with high basal AKT phosphorylation, glucose consumption or glycolysis exhibit a markedly reduced induction of the Pasteur effect in response to metformin and are resistant to metformin-induced apoptosis. Accordingly, glucose starvation or treatment with deoxyglucose or an AKT inhibitor induces sensitivity to metformin. Overall, metformin elicits reprogramming of intermediary metabolism leading to inhibition of cell proliferation in all leukemic cells and apoptosis only in leukemic cells responding to metformin with AKT phosphorylation and a strong Pasteur effect.
Assuntos
Apoptose/efeitos dos fármacos , Hipoglicemiantes/farmacologia , Leucemia/tratamento farmacológico , Leucemia/patologia , Metformina/farmacologia , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Quinases Ativadas por AMP/antagonistas & inibidores , Proteínas Quinases Ativadas por AMP/genética , Proteínas Quinases Ativadas por AMP/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Western Blotting , Proliferação de Células/efeitos dos fármacos , Cromatografia Líquida , Glucose/metabolismo , Glicólise/efeitos dos fármacos , Humanos , Técnicas Imunoenzimáticas , Ácido Láctico/metabolismo , Leucemia/metabolismo , Camundongos , Camundongos Nus , Mitocôndrias/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , RNA Interferente Pequeno/genética , Espectrometria de Massas por Ionização por Electrospray , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
Thyroid-related hormones regulate the efficiency and expression of sarco-endoplasmic reticulum calcium ATPases in cardiac and skeletal muscle. However, little is known about the relationship between thyroid hormones and calcium (Ca2+) homeostasis in the brain. It is hypothesized that manipulating rat thyroid hormone levels would induce significant brain Ca2+ adaptations consistent with clinical findings. Adult male Sprague-Dawley rats were assigned to one of three treatment groups for 28 days: control, hypothyroid (6-n-propyl-2-thiouracil (PTU), an inhibitor of thyroxine (T4) synthesis), and hyperthyroid (T4). Throughout, rats were given weekly behavioral tests. Ca2+ accumulation decreased in the cerebellum in both hyper- and hypothyroid animals. This was specific to different ER pools of calcium with regional heterogeneity in the response to thyroid hormone manipulation. Behavioral tasks demonstrated sensitivity to thyroid manipulation, and corresponded to alterations in calcium homeostasis. Ca2+ accumulation heterogeneity in chronic hyper- and hypothyroid animals potentially explains clinical manifestations of altered thyroid status.
Assuntos
Encéfalo/efeitos dos fármacos , Cálcio/metabolismo , Cerebelo/efeitos dos fármacos , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/metabolismo , Tireoide (USP)/farmacologia , Hormônios Tireóideos/farmacologia , Animais , Comportamento Animal , Western Blotting , Encéfalo/citologia , Encéfalo/metabolismo , Cerebelo/citologia , Cerebelo/metabolismo , Homeostase , Hipertireoidismo/induzido quimicamente , Hipertireoidismo/metabolismo , Masculino , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Microssomos/efeitos dos fármacos , Microssomos/metabolismo , Ratos , Ratos Sprague-Dawley , Tiroxina/toxicidade , Tri-Iodotironina/farmacologiaRESUMO
A growing body of research indicates that amyotrophic lateral sclerosis (ALS) patients and mouse models of ALS exhibit metabolic dysfunction. A subpopulation of ALS patients possesses higher levels of resting energy expenditure and lower fat-free mass compared to healthy controls. Similarly, two mutant copper zinc superoxide dismutase 1 (mSOD1) mouse models of familial ALS possess a hypermetabolic phenotype. The pathophysiological relevance of the bioenergetic defects observed in ALS remains largely elusive. AMP-activated protein kinase (AMPK) is a key sensor of cellular energy status and thus might be activated in various models of ALS. Here, we report that AMPK activity is increased in spinal cord cultures expressing mSOD1, as well as in spinal cord lysates from mSOD1 mice. Reducing AMPK activity either pharmacologically or genetically prevents mSOD1-induced motor neuron death in vitro. To investigate the role of AMPK in vivo, we used Caenorhabditis elegans models of motor neuron disease. C. elegans engineered to express human mSOD1 (G85R) in neurons develops locomotor dysfunction and severe fecundity defects when compared to transgenic worms expressing human wild-type SOD1. Genetic reduction of aak-2, the ortholog of the AMPK α2 catalytic subunit in nematodes, improved locomotor behavior and fecundity in G85R animals. Similar observations were made with nematodes engineered to express mutant tat-activating regulatory (TAR) DNA-binding protein of 43 kDa molecular weight. Altogether, these data suggest that bioenergetic abnormalities are likely to be pathophysiologically relevant to motor neuron disease.
Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Regulação da Expressão Gênica/genética , Doença dos Neurônios Motores/enzimologia , Doença dos Neurônios Motores/genética , Doença dos Neurônios Motores/prevenção & controle , Trifosfato de Adenosina/metabolismo , Animais , Animais Geneticamente Modificados , Animais Recém-Nascidos , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/metabolismo , Proteínas de Ligação a DNA/metabolismo , Modelos Animais de Doenças , Inibidores Enzimáticos/farmacologia , Fertilidade/efeitos dos fármacos , Fertilidade/genética , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/farmacologia , Locomoção/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Doença dos Neurônios Motores/fisiopatologia , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/enzimologia , Mutação/genética , Consumo de Oxigênio/genética , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo , Proteínas Serina-Treonina Quinases/metabolismo , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Interferência de RNA/fisiologia , Ratos , Ratos Sprague-Dawley , Medula Espinal/citologia , Medula Espinal/enzimologia , Superóxido Dismutase/genética , Transativadores/metabolismo , Fatores de Transcrição , TransfecçãoRESUMO
Cells exposed to low-oxygen conditions (hypoxia) alter their metabolism to survive. This response, although vital during development and high-altitude survival, is now known to be a major factor in the selection of cells with a transformed metabolic phenotype during tumorigenesis. It is thought that hypoxia-selected cells have increased invasive capacity and resistance to both chemo- and radiotherapies, and therefore represent an attractive target for antitumor therapy. Hypoxia inducible factors (HIFs) are responsible for the majority of gene expression changes under hypoxia, and are themselves controlled by the oxygen-sensing HIF prolyl hydroxylases (PHDs). It was previously shown that mutations in succinate dehydrogenase lead to the inactivation PHDs under normoxic conditions, which can be overcome by treatment with alpha-ketoglutarate derivatives. Given that solid tumors contain large regions of hypoxia, the reactivation of PHDs in these conditions could induce metabolic catastrophe and therefore prove an effective antitumor therapy. In this report we demonstrate that derivatized alpha-ketoglutarate can be used as a strategy for maintaining PHD activity under hypoxia. By increasing intracellular alpha-ketoglutarate and activating PHDs we trigger PHD-dependent reversal of HIF1 activation, and PHD-dependent hypoxic cell death. We also show that derivatized alpha-ketoglutarate can permeate multiple layers of cells, reducing HIF1alpha levels and its target genes in vivo.
Assuntos
Fator 1 Induzível por Hipóxia/metabolismo , Pró-Colágeno-Prolina Dioxigenase/metabolismo , Animais , Morte Celular/fisiologia , Hipóxia Celular/fisiologia , Ativação Enzimática , Feminino , Células HCT116 , Humanos , Fator 1 Induzível por Hipóxia/genética , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Prolina Dioxigenases do Fator Induzível por Hipóxia , Ácidos Cetoglutáricos/metabolismo , Ácidos Cetoglutáricos/farmacologia , Redes e Vias Metabólicas , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Oxigênio/metabolismo , Transfecção , Proteína Supressora de Tumor Von Hippel-Lindau/metabolismoRESUMO
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Assuntos
Fumarato Hidratase/genética , Mitocôndrias/fisiologia , Neoplasias/fisiopatologia , Succinato Desidrogenase/genética , Genes Supressores de Tumor , Humanos , Mitocôndrias/enzimologia , Neoplasias/enzimologiaRESUMO
One of the many biological functions of nitric oxide is the ability to protect cells from oxidative stress. To investigate the potential contribution of low steady state levels of nitric oxide generated by endothelial nitric oxide synthase (eNOS) and the mechanisms of protection against H(2)O(2), spontaneously transformed human ECV304 cells, which normally do not express eNOS, were stably transfected with a green fluorescent-tagged eNOS cDNA. The eNOS-transfected cells were found to be resistant to injury and delayed death following a 2-h exposure to H(2)O(2) (50-150 microM). Inhibition of nitric oxide synthesis abolished the protective effect against H(2)O(2) exposure. The ability of nitric oxide to protect cells depended on the presence of respiring mitochondria as ECV304+eNOS cells with diminished mitochondria respiration (rho(-)) are injured to the same extent as nontransfected ECV304 cells and recovery of mitochondrial respiration restores the ability of nitric oxide to protect against H(2)O(2)-induced death. Nitric oxide also found to have a profound effect in cell metabolism, because ECV304+eNOS cells had lower steady state levels of ATP and higher utilization of glucose via the glycolytic pathway than ECV304 cells. However, the protective effect of nitric oxide against H(2)O(2) exposure is not reproduced in ECV304 cells after treatment with azide and oligomycin suggesting that the dynamic regulation of respiration by nitric oxide represent a critical and unrecognized primary line of defense against oxidative stress.
Assuntos
Sobrevivência Celular/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Estresse Oxidativo , Consumo de Oxigênio/efeitos dos fármacos , Trifosfato de Adenosina/metabolismo , Azidas/farmacologia , Linhagem Celular , Células Cultivadas , Glucosefosfato Desidrogenase/metabolismo , Humanos , Peróxido de Hidrogênio/farmacologia , Cinética , Medições Luminescentes , NADP/metabolismo , Oligomicinas/farmacologiaRESUMO
Soluble products of activated immune cells include reactive oxygen species (ROS) and nitric oxide (NO) with a high potential to induce biochemical modifications and degenerative changes in areas of inflammation in the central nervous system (CNS). Previously, we demonstrated an increased production of ROS by activated mononuclear cells (MNC) of patients with multiple sclerosis (MS) compared to those of controls, and development of oxidative damage to total DNA in association with inflammation in chronic active plaques. The current study aimed to determine whether mitochondrial (mt)DNA is affected by oxidative damage, and whether oxidative damage to mitochondrial macromolecules (including mtDNA) is associated with a decline in the activity of mitochondrial enzyme complexes. Using molecular and biochemical methods we demonstrate a trend for impaired NADH dehydrogenase (DH) activity and a possible compensatory increase in complex IV activity in association with oxidative damage to mtDNA in chronic active plaques. Immunohistochemistry confirms the increase of oxidative damage to DNA predominantly located in the cytoplasmic compartment of cells in chronic active plaques. These observations suggest that oxidative damage to macromolecules develops in association with inflammation in the CNS, and may contribute to a decline of energy metabolism in affected cells. As observed in neurodegenerative diseases of non-inflammatory origin, decreased ATP synthesis can ultimately lead to cell death or degeneration. Therefore, elucidation of this pathway in MS deserves further studies which may identify neuroprotective strategies to prevent tissue degeneration and the associated clinical disability.
Assuntos
DNA Mitocondrial/química , Mitocôndrias/enzimologia , Esclerose Múltipla/enzimologia , Esclerose Múltipla/patologia , Adolescente , Adulto , Southern Blotting , Encéfalo/patologia , Citrato (si)-Sintase/metabolismo , Dano ao DNA , Transporte de Elétrons/fisiologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Oxirredução , Placa Amiloide/patologiaRESUMO
Mitochondrial oxidative metabolism was examined in two infants with Pompe's disease. The clinical diagnosis was confirmed by the demonstration of intralysosomal glycogen accumulation and a deficiency of acid alpha-D-glucosidase in muscle biopsies. Light and electron microscopy studies demonstrated a normal number of mitochondria with normal ultrastructure. Spectrophotometric measurements revealed that the specific activities of citrate synthase and the partial reactions of electron transport were markedly elevated in the skeletal muscle homogenates prepared from both infants with Pompe's disease when calculated as micromoles per minute per gram wet weight of tissue. However, when respiratory chain enzyme activities were expressed relative to citrate synthase as a marker mitochondrial enzyme, a different pattern emerged, in which all Pompe muscle respiratory enzymes, except complex IV, were decreased relative to control subjects. These observations demonstrate that caution should be exercised when analyzing and interpreting data obtained from tissue homogenates in general and, in particular, in those prepared from tissues in which the wet weight of tissue may be altered, for example, by pathologic accumulation of carbohydrate or lipid.
Assuntos
Glucana 1,4-alfa-Glucosidase/deficiência , Doença de Depósito de Glicogênio Tipo II/diagnóstico , Doença de Depósito de Glicogênio Tipo II/metabolismo , Mitocôndrias/metabolismo , Músculos/metabolismo , Músculos/patologia , Biópsia , Citrato (si)-Sintase/metabolismo , Diagnóstico Diferencial , Transporte de Elétrons , Feminino , Glicogênio/metabolismo , Doença de Depósito de Glicogênio Tipo II/enzimologia , Humanos , Lactente , Recém-Nascido , Mitocôndrias/enzimologia , Músculos/enzimologia , Oxirredução , alfa-GlucosidasesRESUMO
An aqueous fraction (10-300 micrograms/mL) of the ethanol extract of the leaves of Cissampelos sympodialis Eichl inhibited N-formyl-Met-Leu-Phe (fMLP)-induced release of lysozyme and myeloperoxidase from human neutrophils. Inhibition by the fraction, as well as by dibutyryl-cAMP and prostaglandin E2, was substantially greater when the cells were pretreated with the phosphodiesterase (PDE) inhibitor isobutyl methyl xanthine (IBMX) indicating that the effect may be mediated by cAMP. Measurement of intracellular cAMP levels showed that the fraction (30-100 micrograms/mL) increased the nucleotide levels in IBMX-pretreated neutrophils which was unaffected by propranolol. Cyclic AMP dependent protein kinase A activity was also increased by the fraction (1.5-100 micrograms/mL). Superoxide anion generation induced by fMLP in cytochalasin B-treated cells primed with PAF was not inhibited by the aqueous fraction. The results indicate that the aqueous fraction of Cissampelos sympodialis inhibits neutrophil degranulation by a cAMP-dependent mechanism which may be relevant to the use of the plant as an anti-asthmatic agent in folk medicine.
Assuntos
Neutrófilos/efeitos dos fármacos , Extratos Vegetais/farmacologia , Plantas Medicinais/química , Brasil , AMP Cíclico/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Etanol , Humanos , Técnicas In Vitro , Muramidase/metabolismo , Neutrófilos/enzimologia , Neutrófilos/metabolismo , Peroxidase/metabolismo , Folhas de Planta/química , Solventes , Superóxidos/metabolismo , ÁguaRESUMO
Inflammation is a multicomponent system that involves a network of cellular crosstalk and control. Many different cell types, including neutrophils and platelets, participate as both sources and targets of biological mediators that are generated or released in acute and chronic inflammatory states. Owing to the complex nature of inflammation, the magnitude as well as the spatial and temporal characteristics of the responses are likely to vary with the type, concentration, and duration of the inflammatory stimulus. Despite the potential variations in responses to diverse stimuli, a feature common to and responsible for the major characteristics of inflammation (heat, pain, redness, swelling) is proteases. In the early stages of inflammation, the neutrophil is the predominant cell to infiltrate the tissue, and the extent of inflammatory injury has been shown to be directly dependent on the extent of neutrophil infiltration. Since both cathepsin G and elastase are neutral serine proteases present in large amounts in azurophilic granules and are known to affect platelet function, it is thus likely that these neutrophil enzymes are important contributing factors to inflammatory reactions in general and to neutrophil-platelet interactions specifically.
Assuntos
Plaquetas/imunologia , Inflamação/imunologia , Neutrófilos/imunologia , Comunicação Celular , Humanos , Inflamação/metabolismo , Neutrófilos/enzimologia , Serina Endopeptidases/metabolismoRESUMO
Neutrophil cathepsin G and thrombin, the only platelet agonists that are proteases, exhibit a mandatory requirement for catalytic activity to induce platelet aggregation and signal transduction. The thrombin receptor is a G-protein-coupled receptor which undergoes proteolysis to generate a tethered ligand that causes self-activation. Since cathepsin G strongly resembles thrombin in its ability to activate platelets, we have attempted to determine whether cathepsin G and thrombin function through the same or different receptors. Evidence that thrombin and cathepsin G act at different receptors was as follows: (a) an antibody directed against the thrombin receptor blocked thrombin-induced but not cathepsin G-induced platelet responses; (b) human fibroblasts responded to thrombin and to a synthetic thrombin receptor peptide (comprising residues 42-55 of the thrombin receptor) by exhibiting an elevation in cytosolic Ca2+ concentration but did not respond to cathepsin G; and (c) platelets pretreated with neutrophil elastase failed to respond to thrombin but responded when rechallenged by cathepsin G. Thrombin and cathepsin G exhibit heterologous desensitization that is potentiated by okadaic acid and is attenuated by staurosporine, indicating that phosphorylation of serine/threonine residues is important for desensitization and that protein kinase C may be involved. Since catalytic activity of cathepsin G is required for platelet stimulation, it is probable that platelet activation by cathepsin G requires receptor proteolysis and that a tethered ligand mechanism is involved, suggesting that platelets may possess a family of protease receptors.
Assuntos
Plaquetas/metabolismo , Catepsinas/metabolismo , Ativação Plaquetária , Receptores de Superfície Celular/metabolismo , Receptores de Trombina/metabolismo , Trombina/metabolismo , Sequência de Aminoácidos , Cálcio/metabolismo , Catepsina G , Regulação para Baixo , Humanos , Técnicas In Vitro , Elastase de Leucócito/metabolismo , Dados de Sequência Molecular , Elastase Pancreática/metabolismo , Fosfoproteínas/metabolismo , Serina Endopeptidases , Transdução de SinaisRESUMO
We have previously demonstrated that cathepsin G is a strong platelet agonist. However, the ability of cathepsin G to function in this capacity in vivo has remained speculative because the enzyme might be expected to be rapidly neutralized by the high concentration of circulating plasma antiproteases. To examine the physiological significance of cathepsin G as a paracrine mediator, indo-1 and (14)C-5-hydroxytryptamine-loaded platelets were incubated with autologous unloaded neutrophils specifically activated by addition of fMet-Leu-Phe. FMet-Leu-Phe induced substantial increases in cytosolic calcium and 5-hydroxytryptamine release even in the presence of increasing amounts of citrated plasma, indicating that cathepsin G can stimulate platelets under conditions similar to those that may be encountered in vivo. Platelet stimulation was abolished by addition of α1-antichymotrypsin, demonstrating that cathepsin G was the neutrophil mediator responsible for cell activation. Having obtained evidence that cathepsin G can function in the presence of plasma, we measured its ability to hydrolyze phosphatidylinositol 4,5-bisphosphate (PtdIns4,5-P2) and generate phosphatidic acid (PtdA) in aspirin-treated platelets. Our previous observations suggested that cathepsin G stimulates phospholipase C since the protease induces an elevation in [Ca(2+)]i in the presence of exogenous EGTA. Within 10 s of stimulation cathepsin G induced a transient loss in [(32)P]-PtdIns4,5-P2 and a concurrent increase in [(32)P]-PtdA. [(32)P]-PtdA formation was increased over 15-fold in a concentration-dependent manner by cathepsin G. We also determined that cathepsin G induces the release of the lysosomal enzyme ß-N-acetyl-glucosaminidase. Both the increase in PtdA and the release of ß-hexoseaminidase were comparable to responses elicited by thrombin. These results provide additional evidence that cathepsin G is a strong platelet agonist, support the conclusion that cathepsin G stimulates phospholipase C, and clearly suggest that cathepsin G can function as an agonist in vivo.
RESUMO
We showed previously that direct platelet activation by collagen involves an increase in the platelet cytosolic free Ca2+ concentration ([Ca2+]i) but that this increase is not required for the adhesion of platelets to collagen. We now report that collagen-induced arachidonic acid liberation, myosin phosphorylation and 5-hydroxytryptamine secretion are dependent on increases in [Ca2+]i, as they were markedly inhibited in platelets loaded with the acetoxymethyl ester of the Ca2+ chelator BAPTA but not in cells loaded with the acetoxymethyl ester of the non-chelating diazo-3. BAPTA also partially inhibited the rate of collagen-induced phosphatidic acid (PtdA) formation but had little effect on increases in phosphorylation of pleckstrin (47 kDa protein; P47). From these results we infer that collagen-induced increases in [Ca2+]i are required for dense granule secretion and arachidonic acid liberation, but are not necessary for stimulation of the protein kinase C pathway.
Assuntos
Plaquetas/fisiologia , Cálcio/fisiologia , Colágeno/farmacologia , Citosol/fisiologia , Sistemas do Segundo Mensageiro/fisiologia , Marcadores de Afinidade , Sequência de Aminoácidos , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Cálcio/sangue , Ácido Egtázico/análogos & derivados , Ácido Egtázico/farmacologia , Humanos , Cinética , Dados de Sequência Molecular , Miosinas/metabolismo , Ácidos Fosfatídicos/biossíntese , Fosforilação , Ativação Plaquetária/efeitos dos fármacosRESUMO
We have previously demonstrated that human neutrophil cathepsin G is a strong platelet agonist that binds to a specific receptor. This work describes the effect of neutrophil elastase on cathepsin G-induced platelet responses. While platelets were not activated by high concentrations of neutrophil elastase by itself, elastase enhanced aggregation, secretion and calcium mobilization induced by low concentrations of cathepsin G. Platelet aggregation and secretion were potentiated in a concentration-dependent manner by neutrophil elastase with maximal responses observable at 200 nM. Enhancement was observed when elastase was preincubated with platelets for time intervals of 10-60 s prior to addition of a low concentration of cathepsin G and required catalytically-active elastase since phenylmethanesulphonyl fluoride-inhibited enzyme failed to potentiate cell activation. Neutrophil elastase potentiation of platelet responses induced by low concentrations of cathepsin G was markedly inhibited by creatine phosphate/creatine phosphokinase and/or indomethacin, indicating that the synergism between elastase and cathepsin G required the participation of ADP and thromboxane A2. On the other hand, platelet responses were not attenuated by the PAF antagonist BN 52021, signifying that PAF-acether did not play a role in elastase potentiation. At higher concentrations porcine pancreatic elastase exhibits similar effects to neutrophil elastase, demonstrating that the effect of elastase was not unique to the neutrophil protease. While neutrophil elastase failed to alter the ability of cathepsin G to hydrolyze a synthetic chromogenic substrate, preincubation of platelets with elastase increased the apparent affinity of cathepsin G binding to platelets.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Catepsinas/administração & dosagem , Elastase Pancreática/administração & dosagem , Ativação Plaquetária/efeitos dos fármacos , Difosfato de Adenosina/sangue , Sequência de Aminoácidos , Catepsina G , Catepsinas/metabolismo , AMP Cíclico/sangue , Sinergismo Farmacológico , Humanos , Técnicas In Vitro , Dados de Sequência Molecular , Neutrófilos/enzimologia , Oligopeptídeos/química , Elastase Pancreática/sangue , Fator de Ativação de Plaquetas/metabolismo , Ativação Plaquetária/fisiologia , Serina Endopeptidases , Especificidade por SubstratoRESUMO
The adhesion of platelets to collagen and their activation is the primary event in haemostasis. Following adhesion, platelet aggregation mediated by ADP, thromboxane A2 and thrombin leads to the formation of a platelet plug. It is known that platelet activation by each of these agonists involves an increase in the cytosolic free Ca2+ concentration, and this has been thought to be controlled by cyclic AMP. However, we report here that while signal transduction induced by ADP plus a thromboxane mimetic (U46619), or by thrombin, is inhibited by stimulators of adenylate cyclase such as a prostaglandin I2 (PGI2) analogue (Iloprost), PGD2 and forskolin, elevation of cyclic AMP does not inhibit either platelet adhesion to collagen or the associated Ca2+ mobilization, phosphatidic acid formation or 5-hydroxytryptamine secretion. Furthermore, collagen did not lower elevated levels of cyclic AMP in platelets measured in the presence of both a thromboxane antagonist and an ADP-removing system. The present results are discussed in the context of previous findings.
Assuntos
Plaquetas/metabolismo , Colágeno/farmacologia , AMP Cíclico/farmacologia , Transdução de Sinais/efeitos dos fármacos , Difosfato de Adenosina/farmacologia , Plaquetas/efeitos dos fármacos , Cálcio/sangue , AMP Cíclico/sangue , Corantes Fluorescentes , Fura-2 , Humanos , Iloprosta/farmacologia , Adesividade Plaquetária/efeitos dos fármacos , Prostaglandina D2/farmacologia , Endoperóxidos Sintéticos de Prostaglandinas/farmacologia , Serotonina/sangue , Trombina/farmacologiaRESUMO
Prostaglandin-regulated cyclic AMP metabolism in human erythroleukaemia (HEL) cells was similar to that previously described in platelets [Ashby (1989) Mol. Pharmacol. 36, 866-873], displaying prostaglandin-concentration-dependent desensitization that could be explained by the presence of separate stimulatory and inhibitory prostaglandin receptors. Pertussis toxin abolished prostaglandin-concentration-dependent desensitization, indicating that the process is mediated through a pertussis toxin-sensitive GTP-binding protein. Treatment of HEL cells for 4 days with the inducer dimethyl sulphoxide enhanced prostaglandin-concentration-dependent desensitization, but did not alter the initial rate of cyclic AMP synthesis or the amount of Gi2 alpha measured by immunoblotting, suggesting that the inhibitory receptor was selectively induced by changing the cells to a more platelet-like form.
Assuntos
Toxina Adenilato Ciclase , Adenilil Ciclases/efeitos dos fármacos , Alprostadil/farmacologia , Dimetil Sulfóxido/farmacologia , Leucemia Eritroblástica Aguda/metabolismo , Toxina Pertussis , Fatores de Virulência de Bordetella/farmacologia , Adenilil Ciclases/metabolismo , AMP Cíclico/metabolismo , Epinefrina/farmacologia , Humanos , Iloprosta/farmacologia , Células Tumorais CultivadasRESUMO
The attachment of platelets to collagen-coated microtiter plates at 20 degrees C was inhibited strongly by depletion of metabolic energy or by addition of cytochalasins and was slightly inhibited by the intracellular Ca2+ chelator BAPTA. In keeping with their respective potencies as inhibitors of actin polymerization, cytochalasins D and H were the most potent inhibitors of adhesion, while cytochalasin B was the least potent. Energy depletion, cytochalasin D or, to a much lesser extent, BAPTA also inhibited platelet adhesion to collagen in a suspension assay system at 37 degrees C. Collagen-induced platelet cytosolic Ca2+ mobilization was inhibited up to 70% by cytochalasin D and abolished by energy depletion or BAPTA. Elevation of intracellular platelet calcium by treatment with ionomycin had little effect on platelet adhesion to collagen. We propose that rapid platelet spreading along collagen fibers is both energy- and actin-dependent and necessary to produce maximal adhesion needed to elicit Ca2+ mobilization required for subsequent responses.